维普中文期刊产品整合服务
28篇 您的检索式:作者名="Hensing T"
    题名 作者 年代 出处 被引量
1Bed sharing and risk of sudden infant death syndrome can we resolve the debate? 显示文摘Vennemann MM Hense HW Bajanowski T 2012J Pediatr2012,160,1:1
2Personalized treatment of lung cancer显示文摘Salgia R Hensing T Campbell N 2011Semin Oncol2011,38,2:1
3Molecular pathways and therapeutic targets in lung cancer显示文摘Shtivelman E Hensing T Simon GR 2014Oncotarget2014,5,6:1
4Personalized treatmentof lung cancer显示文摘Salgia R Hensing T Campbell N 2011Sermin Oncol2011,38,2:1
5Personalized Treat-ment of Lung Cancer显示文摘Salgia R Hensing T Campbel N 0,,02:1
6BNP as a marker of diastolic dysfunction in the general population : importance of left ventricular hypertrophy 显示文摘LUKOWICZA T V FISCHERA M HENSE H W 2005Eur J Heart Fail2005,7,4:1
7Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition) 显示文摘Socinski M A Crowell R Hensing T E 2007Chest2007,132,3:1
8Personalized treatment of lung cancer显示文摘Salgia R Hensing T Campbell N 0,,02:1
91 Third genera- tion chemotherapy regimens (3GR) improve survival over second generation regimens (2GR) in stagel]I B/IV non-small cell lung cancer (NSCLC): a meta-analysis of the published literature显示文摘Baggstrom M Socinski MA Hensing T eta 2002Proc Am Soc Clin Oncol2002,21,3:1
10Personalizedtreatment of lung cancer显示文摘SALGIA R HENSING T CAMPBELL N 2011Semin Oncol2011,38,2:1
11Phase II study of BBR 3464 as treatment in patients with sensitive or refractory small cell lung cancer显示文摘Hensing T A Hanna N H Gillenwater H H 2006Anti -Cancer Drugs2006,17,6:1
12Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer显示文摘Hensing T A Schell M J Lee J H 2005Lung Cancer2005,47,2:1
13Personalized treatment of lung cancer显示文摘Salgia R Hensing T Campbell N 2011Semin 0ncol2011,38,:1
14Hyperproca lc-itonemia in patien tswith noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass显示文摘Hense LM Volk T Docke WD 2010Anesthesiology2010,89,:1
15Hommone replacement therapy and interrelation between serum IL -6 and body mass index in postmenopausal women : A population based study 显示文摘Straub RH Hense HW Andus T 2000J Clin Endocrinol Metab2000,85,5:1
16Treatment of non- small cell lung cancer, stage Ⅳ: ACCP evidence-based clinical practive guidelines (2nd edition)显示文摘Socinski M A Croweu R Hensing T E 2007Chest2007,7,5:1
17Third generation chemotherapy regimens (3GR) improve survival over second generation regimens (2GR) in stage Ⅲ B/Ⅳ non-small cell lung caner (NSCLC):a meta-analysis of the published literature显示文摘Baggstrom M Socinski M A Hensing T 2002Proc Am Soc Clin Oncol2002,21,2:1
18The polymerase chain reaction and plant disease diagnosis显示文摘HENSE T J FRENCH R 1993Annu Rev Phytopathol1993,,31:1
19Personalized treatment of lung cancer显示文摘Salgia R Hensing T Campbell N 2011Semin Oncol2011,38,:1
20Phase II study of BBR 3464 as treatment in patients with sensitive or refractory small cell lung cancer显示文摘HENSING T A HANNA N H GILLENWATER H H 2006Anti-Cancer Drugs2006,17,6:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费